Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials

OBJECTIVES: (1) To assess if co-administration of four-component meningococcal serogroup B vaccine (4CMenB) and other routine vaccines caused an interaction increasing the risk and/or severity of adverse events following immunisation (AEFI) compared with administration at separate visits and (2) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafack, Joseline Guetsop, Bureau, Alexandre, Skowronski, Danuta M, De Serres, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530311/
https://www.ncbi.nlm.nih.gov/pubmed/31110098
http://dx.doi.org/10.1136/bmjopen-2018-026953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530311/
https://www.ncbi.nlm.nih.gov/pubmed/31110098
http://dx.doi.org/10.1136/bmjopen-2018-026953

Ejemplares similares